[go: up one dir, main page]

NO994395L - Stable, solid formulation containing vitamin D3 and tricalcium phosphate - Google Patents

Stable, solid formulation containing vitamin D3 and tricalcium phosphate

Info

Publication number
NO994395L
NO994395L NO994395A NO994395A NO994395L NO 994395 L NO994395 L NO 994395L NO 994395 A NO994395 A NO 994395A NO 994395 A NO994395 A NO 994395A NO 994395 L NO994395 L NO 994395L
Authority
NO
Norway
Prior art keywords
tricalcium phosphate
stable
formulation containing
solid formulation
containing vitamin
Prior art date
Application number
NO994395A
Other languages
Norwegian (no)
Other versions
NO994395D0 (en
Inventor
Achim Schoffler
Claudia Wildner
Original Assignee
Merck Patent Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merck Patent Gmbh filed Critical Merck Patent Gmbh
Publication of NO994395D0 publication Critical patent/NO994395D0/en
Publication of NO994395L publication Critical patent/NO994395L/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/06—Aluminium, calcium or magnesium; Compounds thereof, e.g. clay
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/42—Phosphorus; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Rheumatology (AREA)
  • Inorganic Chemistry (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

Oppfinnelsen vedrører et farma- søytisk preparat som inneholder en aktiv form av vitamin D3 og trikal- siumfosfat, for behandling av osteo- porose og lårhalsbrudd, vitamin D3- og/eller kalsiummangeltilstander samt Fagets sykdom.The invention relates to a pharmaceutical composition containing an active form of vitamin D3 and tricalcium phosphate, for the treatment of osteoporosis and femoral neck fractures, vitamin D3 and / or calcium deficiency conditions and the subject's disease.

NO994395A 1997-03-12 1999-09-10 Stable, solid formulation containing vitamin D3 and tricalcium phosphate NO994395L (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE19710054A DE19710054A1 (en) 1997-03-12 1997-03-12 Pharmaceutical preparation
PCT/EP1998/001208 WO1998040085A1 (en) 1997-03-12 1998-03-04 Stable solid preparation containing vitamin d3 and tricalcium phosphate

Publications (2)

Publication Number Publication Date
NO994395D0 NO994395D0 (en) 1999-09-10
NO994395L true NO994395L (en) 1999-09-10

Family

ID=7823015

Family Applications (1)

Application Number Title Priority Date Filing Date
NO994395A NO994395L (en) 1997-03-12 1999-09-10 Stable, solid formulation containing vitamin D3 and tricalcium phosphate

Country Status (20)

Country Link
EP (1) EP0969849B1 (en)
JP (1) JP2001515486A (en)
KR (1) KR20000076042A (en)
CN (1) CN1249689A (en)
AR (1) AR010903A1 (en)
AT (1) ATE245425T1 (en)
AU (1) AU730675B2 (en)
BR (1) BR9808233A (en)
CA (1) CA2284183A1 (en)
CZ (1) CZ290991B6 (en)
DE (2) DE19710054A1 (en)
DK (1) DK0969849T3 (en)
ES (1) ES2201460T3 (en)
HU (1) HUP0002928A3 (en)
NO (1) NO994395L (en)
PL (1) PL335644A1 (en)
PT (1) PT969849E (en)
SK (1) SK121699A3 (en)
WO (1) WO1998040085A1 (en)
ZA (1) ZA982073B (en)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6479474B2 (en) * 1999-07-08 2002-11-12 Wisconsin Alumni Research Foundation Dietary calcium as a supplement to vitamin D compound treatment of multiple sclerosis
JPWO2003070716A1 (en) * 2002-02-20 2005-06-09 帝人株式会社 Vitamin D3 derivative and therapeutic agent using the same
EP1342796A3 (en) * 2002-02-22 2004-01-02 Teijin Limited Compound for the treatment of paget's disease of bone
PT2266585E (en) * 2003-05-07 2013-07-09 Osteologix As Water-soluble strontium salts for use in treatment of cartilage and/or bone conditions
RU2268053C1 (en) * 2004-05-05 2006-01-20 Григорий Николаевич Коныгин Method for treating hypocalcemia, osteoporosis , fractures
TR200900880A2 (en) 2009-02-05 2010-08-23 Bi̇lgi̇ç Mahmut Pharmaceutical compositions combined in a single dosage form.
TR200900878A2 (en) 2009-02-05 2010-08-23 Bi̇lgi̇ç Mahmut Pharmaceutical formulations combined in a single dosage form
US9757331B2 (en) 2010-06-24 2017-09-12 Prayon Sa Stabilized active compound
SG11201507957VA (en) 2013-03-27 2015-10-29 Psm Healthcare Ltd Stabilized vitamin d formulations
EP3042649A1 (en) * 2015-01-09 2016-07-13 S.B.M. S.r.l. A composition, comprising tricalcium phosphate and gelatin, for treating dyspepsia and related disorders
CN105982071A (en) * 2015-02-05 2016-10-05 宁志伟 High-dose vitamin D3 oral preparation recipe
CN104800166B (en) * 2015-04-22 2017-11-10 青岛正大海尔制药有限公司 A kind of Alfacalcidol powder and preparation method thereof
CN113350374B (en) * 2021-06-23 2022-05-31 锦州医科大学 Preparation method of calcium phosphate and vitamin D composite microcapsule

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2525478B2 (en) * 1989-03-01 1996-08-21 帝人株式会社 Active Vitamin D with improved stability (3) Lower solid preparation
JP3147249B2 (en) * 1992-03-11 2001-03-19 コベルコ建機株式会社 Control device for traveling pump pressure
IL103224A (en) * 1992-09-18 1998-08-16 Teva Pharma Stabilized pharmaceutical compositions containing derivatives of vitamins d2 and d3
US5548203A (en) * 1994-06-29 1996-08-20 Electric Power Research Institute, Inc. Capacitor polarity-based var correction controller for resonant line conditions and large amplitude line harmonics
FR2724844B1 (en) * 1994-09-23 1997-01-24 Innothera Lab Sa VITAMIN-CALCIUM THERAPEUTIC COMBINATION, PROCESS FOR OBTAINING SAME AND USE THEREOF
IL115241A (en) * 1994-09-26 2000-08-31 American Cyanamid Co Calcium dietary supplement

Also Published As

Publication number Publication date
NO994395D0 (en) 1999-09-10
AR010903A1 (en) 2000-07-12
KR20000076042A (en) 2000-12-26
EP0969849B1 (en) 2003-07-23
AU730675B2 (en) 2001-03-08
SK121699A3 (en) 2000-01-18
HUP0002928A2 (en) 2001-02-28
DE59809085D1 (en) 2003-08-28
JP2001515486A (en) 2001-09-18
EP0969849A1 (en) 2000-01-12
WO1998040085A1 (en) 1998-09-17
ATE245425T1 (en) 2003-08-15
CN1249689A (en) 2000-04-05
ZA982073B (en) 1998-09-16
DE19710054A1 (en) 1998-09-17
BR9808233A (en) 2000-05-16
CZ290991B6 (en) 2002-11-13
DK0969849T3 (en) 2003-11-03
PT969849E (en) 2003-12-31
HUP0002928A3 (en) 2001-04-28
PL335644A1 (en) 2000-05-08
CZ322199A3 (en) 2000-01-12
ES2201460T3 (en) 2004-03-16
CA2284183A1 (en) 1998-09-17
AU6499798A (en) 1998-09-29

Similar Documents

Publication Publication Date Title
NO994395L (en) Stable, solid formulation containing vitamin D3 and tricalcium phosphate
BR9808348A (en) Medicinal food for diabetics
NO20063853L (en) Combination therapy for osteoporosis
AR015946A1 (en) PHARMACEUTICAL FORMULATION THAT INCLUDES BIFOSPHONATES, PROCESS FOR PREPARATION, USE OF THE FORMULATION FOR THE MANUFACTURE OF A MEDICINAL PRODUCT, PARALA METHOD INHIBITION OF OSEA REABSORTION, AND METHOD FOR THE TREATMENT AND PREVENTION OF OSTEOPOROSIS
YU18400A (en) Prostaglandin agonists and their use to treat bone disorders
WO1999032135A8 (en) Keratinocyte growth factor-2 formulations
SE9901272D0 (en) New improved formulation
ES2190244T3 (en) USE OF THE PARTIROID HORMONE CONSTITUTED BY A SEQUENCE OF AMINO ACIDS 1-34 OF THE HUMAN PARTIROID HORMONE TO REDUCE THE RISK OF VERTEBRAL AND NON-VERTEBRAL BONE FRACTURES.
MX9307569A (en) DRY MIX FORMULATION FOR BISPHOSPHONIC ACIDS.
DE69501419D1 (en) Pharmaceutical composition for the treatment of osteoporosis containing xanthohumol
DE60239343D1 (en) MEDICINE FOR THE TREATMENT OF DISEASES COMING WITH BONE SCUM, WITH EP4 AGONIST AS AN ACTIVE AGENT
IL78342A (en) Pharmaceutical composition for treatment of osteoporosis in humans comprising a parathyroid hormone or a fragment thereof
BG100911A (en) Biophosphonic acids-sontaining wet-granulated form
BR9810832B1 (en) a pharmaceutical composition containing calcium salt-associated vitamin d as an active ingredient; and processes for the preparation of a pharmaceutical composition for the treatment of nutritional deficiencies of calcium and vitamin d in old age and to reduce age-related loss of bone tissue and to prevent femoral and other nonvertebral fractures.
WO1998058911A3 (en) Prostaglandin agonists
ES2129485T3 (en) DERIVATIVES OF GUANIDINOALKYL-1,1-BISPHOSPHONIC ACIDS, PROCEDURE FOR THEIR PREPARATION AND USE.
DE69919533D1 (en) PROTEIN-BASED MEDICINAL PRODUCTS
ITMI931649A1 (en) DERIVATIVES OF 2-AMINO-4-PHENYL-4-BUTYRIC BONE ACID
AU3868997A (en) Pharmaceutical composition containing osteogenesis-promoting substance and a polyethylene glycol
BR9608392A (en) Multiparticulate controlled-release preparation and tablet dosage form.
DK0762883T3 (en) Pyridyl bisphosphonates for use as therapeutic agents
AR019025A1 (en) USE OF ERYTHROPOYETIN IN LOW DOSE TO PRODUCE A PHARMACEUTICAL PREPARATION FOR THE TREATMENT OF HEMOCROMATOSIS, COMBINED PHARMACEUTICAL PREPARATION USED ACCORDING TO SUCH USE AND PHARMACEUTICAL UNIT PACKAGING CONTAINING THE PHARMACEUTICAL COMBINED PREPARED REFERENCE
DE69915852D1 (en) LHRH ANALOGA FOR TREATING OSTEOPOROSIS
ATE73664T1 (en) PHARMACEUTICALS FOR THE REGULATION OF HORMONAL SECRETIONS AND THE TREATMENT OF FEMALE STERILITY.
FR2803521B1 (en) USE OF TILUDRONIC ACID AND ITS DERIVATIVES IN POULTRY FOR THE PREPARATION OF A MEDICINAL PRODUCT FOR PREVENTING AND TREATING OSTEOPOROSIS